Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Facing the Inevitable: Being Prepared for Regulatory Requirements for Laboratory Developed Tests.

PMID: 29659675 · 2018

JournalAmerican journal of clinical pathology
Year2018
PMID29659675

Abstract

We introduce regulatory terms, definitions, and the Quality System Regulation as proposed by the US Food and Drug Administration in the 2014 draft guidance entitled Framework for Regulatory Oversight of Laboratory Developed Tests and explore medical device requirements applicable to a laboratory environment to design, develop, and validate laboratory developed tests (LDTs). We performed nine interviews with laboratory professionals to explore concerns and challenges regarding the draft, translat

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.